GT Financial's (Tolpigin) parting comment from yesterdays report - "Investors should continue to hold IBA as our focus remains on the $1.50 level and the enormous opportunities present over the next two years."
- Forums
- ASX - By Stock
- IBA
- one to watch
IBA
iba health group limited
one to watch, page-9
Featured News
Add IBA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online